Mirae Asset Venture Investment — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.
BiotechHealthtechLongevity
Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupJJDC+1 more
Dalpha builds AI technology, including a system it calls the Cobra World Model, focused on predicting human behavior to generate insights.
AI & Machine LearningEnterprise Software
Yoo Seon-bin(Co-Founder)Kim Do-gyun(CEO)
Co-investorsDunamu & PartnersSazzeDSC InvestmentIMM InvestmentIntervestPrimer Sazze Partners
Neocis develops Yomi, a robotic surgical platform that assists clinicians during dental implant surgery with planning, surgical, and restorative software features.
HealthtechMedical DevicesRoboticsMiami, US
Alon Mozes(CEO & Co-Founder)inJuan Salcedo(Engineering Fellow & Co-Founder)inJUAN SALCEDO(Executive Officer)inALON MOZES(Executive Officer, Director)inDennis Moses(Chief Technical Officer)inAndres Carrillo(VP of Product)in
Co-investorsIntuitive VenturesNorwest Venture PartnersVivo CapitalMITHRILB Capital GroupMithril Capital Management+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.